FDA Drug Recalls

Recalls / Class II

Class IID-1514-2014

Product

Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, NJ 08560 NDC 50458-306-11

Brand name
Risperdal Consta
Generic name
Risperidone
NDCs
50458-306, 50458-309, 50458-307, 50458-308
FDA application
NDA021346
Affected lot / code info
Vial - 4212AAP1, Kit - 309316, Exp. 07/15

Why it was recalled

Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample

Recalling firm

Firm
Janssen Pharmaceuticals, Inc.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
1125 Trenton Harbourton Rd, N/A, Titusville, New Jersey 08560-1503

Distribution

Quantity
70,495 kits
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-09-11
FDA classified
2014-08-05
Posted by FDA
2014-08-13
Terminated
2015-01-23
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1514-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.